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Abstract Ras-GRF is a guanine nucleotide exchange factor 
that activates Ras proteins. Its activity on Ras in cells is 
enhanced upon calcium influx. Activation follows calcium-
induced binding of calmodulin to an IQ motif near the N-
terminus of Ras-GRF. Ras-GRF also contains a Dbl homology 
(DH) domain C-terminal to the IQ motif. In many proteins, DH 
domains act as exchange factors for Rho-GTPase family 
members. However, we failed to detect exchange activity of this 
domain on well characterized Rho family members. Instead, we 
found that mutations analogous to those that block exchange 
activity of Dbl prevented Ras-GRF activation by calcium/ 
calmodulin in vivo. All DH domains are followed immediately 
by a pleckstrin homology (PH) domain. We found that a 
mutation at a conserved site within the PH domain following the 
DH domain also prevented Ras-GRF activation by calcium in 
vivo. These results suggest that in addition to playing a role as 
activators of Rho proteins, DH domains can also contribute to 
the coupling of cellular signals to Ras activation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Ras proteins are members of a superfamily of GTPases that 
cycle between the active GTP and inactive GDP bound states. 
These proteins become activated upon interaction with gua-
nine nucleotide exchange factors (GEFs), which promote the 
release of GDP from Ras and allow its replacement with 
activating GTP. Ras proteins become deactivated when they 
hydrolyze GTP to GDP, a process that is enhanced by the 
interaction with GTPase activating proteins (GAPs) (for re-
view see [1]). 
Depending on the cell type and stimulus, Ras proteins can 
influence cell proliferation, differentiation or functions associ-
ated with non-dividing fully differentiated cells [2]. Ras pro-
teins perform these functions by coupling signals originating 
at the cell surface to intracellular signaling cascades. At 
present, three classes of downstream effector proteins are 
known to be regulated upon binding to activated Ras in cells : 
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(1) Raf protein kinases, which initiate a cascade of kinase 
activations including MEK and ERK [3] ; (2) a phosphatidyl-
inositol 3-kinase (PI 3-kinase), whose lipid product activates 
the Akt kinase [4-6] and non-conventional PKC isoforms 
[7,8]; and (3) a guanine nucleotide exchange factor that acti-
vates the Ral-GTPases [9-12]. 
In most cases studied to date, Ras proteins become acti-
vated in response to an increase in the activity of GEFs (for 
review see [13]), although examples of inhibition of GAP ac-
tivity also have been documented [14]. In mammalian cells, 
regulatory pathways involving two classes of exchange fac-
tors, termed SOS and Ras-GRF (or CDC25 Mm), have 
been identified. SOS mediates tyrosine kinase receptor activa-
tion of Ras through its binding to the adapter protein Grb2 
(for review see [13]). Some G protein-linked receptors are also 
thought to activate Ras via SOS [15]. One characterized path-
way involves activation of the cytoplasmic PYK2 tyrosine 
kinase in response to elevated calcium levels [16], while others 
involve Src family tyrosine kinases [17-19]. 
Calcium can also activate Ras without the involvement of 
tyrosine kinase stimulation via the exchange factor Ras-GRF 
[20]. Such a mechanism may account for Ras activation asso-
ciated with depolarization of primary cortical neurons [20]. 
Ras-GRF does not have a Grb2 binding site, but instead 
contains a calmodulin-binding IQ domain near its N-termi-
nus. Ras-GRF activity is enhanced in cells upon elevated cal-
cium levels, and this activation is dependent upon calmodulin 
binding to the IQ domain [20]. Ras-GRF activity has also 
been shown to be enhanced upon Ml and M2 muscarinic 
receptor activation, apparently through the liberation of ßy 
subunits of activated G proteins [21]. In this case the activat-
ing event is thought to be phosphorylation. 
Ras-GRF contains additional conserved domains that are 
found in many other signaling molecules. N-terminal to the 
catalytic domain that activates Ras is a domain which shares 
homology with the proto-oncogenic protein Dbl [22,23]. A 
similar domain is also found in SOS [1]. Dbl is a GEF for 
the Rho A and CDC42 GTPases [24,25]. Along with Rac, 
Rho G and TC10, these proteins make up the Rho family 
of GTP binding proteins, some of which have been shown 
to regulate the actin cytoskeleton [26] distinct protein kinase 
cascades (for review see [27]). Many other proteins containing 
Dbl homology (DH) domains exhibit in vitro nucleotide ex-
change activity towards discrete sets of Rho family GTPases. 
For example, Ost activates RhoA and CDC42 [28], Lbc acti-
vates Rho A, B and C [29], Tiaml activates Rac, RhoA and 
CDC42 [30], Abr and BCR activate CDC42, Rac and Rho 
[31], and CDC24 activates CDC42 [32]. Many Dbl-containing 
proteins have oncogenic potential presumably by virtue of 
their ability to activate Rho family proteins in vivo. 
All known DH domains are followed directly by a pleck-
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strin homology (PH) domain [27]. Although the P H domain 
of Dbl is not required for exchange activity in vitro, it is 
required for in vivo transforming activity of Dbl [27]. P H 
domains without neighboring D H domains are also found 
in a wide variety of signaling molecules such as protein kin-
ases (ßARK-1 , Akt /PTB and BTK), GTPases (dynamin) and 
cytoskeletal proteins (ß-spectrin) [33]. P H domains are about 
100 amino acids in length and may contain binding sites for 
lipids, such as PIP2 (for review see [34]) and part of a binding 
site for proteins, such as the ßy subunits of G proteins [35]. 
These interactions may target P H domain-containing proteins 
to membranes. 
The aim of this work was to investigate the role of the D H 
and its associated P H domain in R a s - G R F function. Initially, 
we screened a wide range of Rho family GTPases as potential 
downstream targets for R a s - G R F . To our surprise, R a s - G R F 
did not function as an exchange factor for any of the GTPases 
tested. However, we did find that intact D H and PH2 do-
mains were required for the efficient calcium-mediated activa-
tion of R a s - G R F . Although we cannot rule out that this D H 
domain is an activator of an untested Rho family GTPase, the 
results of this work suggest that it plays an important role in 
the ability of R a s - G R F to activate Ras in response to calcium. 
2. Materials and methods 
2.1. Plasmids and recombinant DNA 
Constructions of expression vectors for Ras-GRF, NGlu-Ras-GRF, 
Ras-GRF(IQ-), pJ3M-ERKl, and pMT3-Rasl7N have been de-
scribed previously [20]. NGlu-Ras-GRF(DH—) was constructed by 
overlap PCR using outside primers encoding the Glu tag and the 
amino terminus of Ras-GRF [20] and codons 570-575, and internal 
primers introducing IIIRDII at codons 390-396. The PCR product 
was cut with Notl and Aflil and subcloned into full length NGlu-Ras-
GRF at the same sites. NGlu-Ras-GRF(PH2—) was constructed in a 
similar manner except that the outside primers were at codons 218-
231 and 689-695 and the inside primers introduced W to A and I to A 
at codons 573 and 577 respectively. The PCR product was digested 
with Bgäl and PflmI and ligated into wild type Ras-GRF previously 
cut at the same sites. DNA sequencing confirmed the expected nucleo-
tide alterations. 
2.2. Cell culture and transfections 
293T and COS-7 cells were maintained in Dulbecco's modified Ea-
gle's medium containing 100 U/ml penicillin, 100 ug/ml streptomycin 
(Gibco BRL) and 10% iron-supplemented defined bovine calf serum 
(Hyclone). Cells were seeded at a density of 1-2 X105 cells per 60 mm2 
dish 24 h prior to transfection. Cells were transfected with the indi-
cated amounts of DNA by calcium phosphate precipitation (for 293T 
cells) or by the DEAE-dextran method (for Cos cells). 
2.3. Cell stimulation, lysis and immunoprecipitation 
Cells were serum starved for 16 h where indicated. 60 mm2 dishes 
were incubated in 1 ml DMEM containing either 5 uM ionomycin 
(Calbiochem) for 5 min or buffer alone. After stimulation, the dishes 
were placed on ice, washed in 3 ml of ice cold phosphate-buffered 
saline (PBS) and scraped into 1 ml of PBS. The cells were collected in 
a microfuge at 5000 rpm for 4 min, resuspended in 250 ul of mild 
buffer (20 mM Tris-HCl pH 7.4, 125 uM NaCl, 1 mM MgCl2) con-
taining 1% Triton X-100, 50 mM sodium fluoride, 25 mM ß-glycer-
ophosphate, 100 uM sodium orthovanadate, 1 mM phenylmefhylsul-
fonyl fluoride (PMSF), 10 ug/ml aprotinin and 10 ug/ml leupeptin and 
left on ice for 10 min with occasional vortexing. The extracts were 
centrifuged at 15000Xg for 10 min at 4°C and the supernatant re-
moved. 50 ul of each supernatant was removed for immunoblotting 
and total protein determination and epitope-tagged proteins were im-
munoprecipitated by incubating 200 |xl of each extract for 2 h at 4°C 
with 20 ul (1:1 slurry) of protein A Sepharose (Pharmacia) and the 
designated antibody (1:40 dilution of anti-myc 9E10 hybridoma 
supernatant; 1:100 dilution of anti-Glu hybridoma supernatant). 
2.4. Protein kinase assays 
ERK1 kinase assays were performed as previously described [20]. 
Briefly, immunoprecipitates were washed twice with PBS containing 
1% Triton X-100 and twice with kinase buffer (50 mM Tris-HCl pH 
7.4. 5 mM MgCl2, 1 mM DTT). Immune complex phosphorylation 
reactions were performed at 20°C in 30 |xl of kinase buffer containing 
50 mM sodium fluoride, 25 mM ß-glycerophosphate, 100 uM sodium 
orthovanadate, 25 uM ATP, 0.1 uCi/ul [y-32P]ATP and 50 ug/ml of 
myelin basic protein. Reactions were stopped by the addition of 10 ul 
4xLaemmli sample buffer and phosphorylated proteins were visual-
ized and quantitated after SDS-PAGE using a phosphorimager (Mo-
lecular Dynamics). 
2.5. Preparation of GDP-bound GST-Ras 
GST-Ras was overexpressed and purified from bacteria. The fusion 
protein was eluted from glutathione beads by washing in exchange 
buffer (20 mM Tris-HCl pH 8, 100 mM NaCl, 40 ug/ml BSA, 1 mM 
MgCl2, 2 mM DTT) containing 10 mM glutathione. The eluate was 
dialyzed overnight at 4°C against exchange buffer containing 2 uM 
GDP. An aliquot of the GST-Ras was visualized with Coomassie 
brilliant blue after SDS-PAGE to estimate the protein concentration. 
The GTPase was adjusted to a final concentration of 3 uM and 100 ul 
of each were incubated on ice for 15 min with 100 ul of exchange 
buffer containing 1.5uM GDP. 
2.6. In vitro Ras exchange assay 
10x100 mm2 dishes of subconfluent 293T cells were transfected 
with 10 ug of either pMT3 NGluRas-GRF, NGluGRF(DH-) or 
NGluGRF(PH2—). Cell extracts were prepared as described above, 
except that each dish was extracted into 100 ul of lysis buffer. 
NGluGRF was immunoprecipitated from the extracts by incubation 
for 2 h at 4°C with 100 ul of a 1:1 slurry of protein A Sepharose 
which had been pre-bound to 10 ul of anti-Glu antibody. Immuno-
precipitated NGluGRF was washed three times in mild buffer con-
taining 0.5 mM CaCl2 and 1% Triton X-100, and three times in mild 
buffer containing 0.5 mM CaCl2 and 0.1% Triton X-100. Purified 
NGluGRF was eluted from the immune complex by incubation for 
1 h at 4°C with a peptide of the Glu epitope (0.2 mg/ml). 5 ul of the 
GDP-loaded GST-Ras described above was incubated at 30°C for the 
indicated times with 35 ul of exchange buffer containing 2 uCi of [a-
32P]GTP and 100 ng of wild type or mutant NGluGRF or buffer 
alone containing Glu peptide. To determine the maximal binding of 
[a-32P]GTP to GDP-Ras, 4.5 mM EDTA was added instead of 
NGluGRF. The mixture was incubated at 30°C for 5 min, MgCl2 
was added to a final concentration of 6 mM and incubated at 30°C 
for a further 5 min. 10 ul of each assay was spotted onto 1 cm2 square 
pre-moistened nitrocellulose membrane and was washed with 4 ml of 
Tris-HCl-buffered saline containing 5 mM MgCl2. The amount of [a-
32P]GTP bound to the membrane was quantitated by Cerenkov 
counting. 
2.7. Subcellular fractionation of 293T cells 
293T cells were transiently transfected with 3 ug of pMT3 Ras-
GRF or Ras-GRF mutants in each 60 mm2 dish. Cells were harvested 
as described above except that the cell pellets were resuspended in 125 
Ul of isotonic lysis buffer (20 mM Tris-HCl pH 7.5, 125 mM NaCl, 
1 mM MgCl2, 1 mM PMSF, 10 ug/ml aprotinin and 10 ug/ml leu-
peptin, 50 mM sodium fluoride, 25 mM ß-glycerophosphate and 100 
uM sodium orthovanadate) and sonicated. Samples were then micro-
fuged at lOOOOXg for 10 min at 4°C. The supernatants were removed 
and centrifuged at 100 000 X g for 45 min at 4°C. The supernatant was 
removed and the pellet resuspended in 120 ul of lysis buffer containing 
1% Triton X-100. 10 ug of each extract was separated by SDS-PAGE 
and Ras-GRF was identified by immunoblotting using a peptide 
antiserum against the C-terminal 20 residues of the protein (Santa 
Cruz). 
3. Results 
3.1. Functional DH and PH2 domains of Ras-GRF are required 
for activation by calcium 
By virtue of its sequence similarity to Dbl, the D H domain 
of R a s - G R F has been proposed to be an exchange factor for 
R h o family GTPases. However, we have found that R a s - G R F 
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Fig. 1. Domain structure of wild type Ras-GRF indicating DH(—) 
and PH2(—) mutants. The N-terminus of Ras-GRF contains two 
domains which share homology with pleckstrin (PHI and PH2), 
and one domain which shares homology with the oncoprotein Dbl 
(DH). To investigate the role of these conserved regions in Ras-
GRF activation, we made mutations as indicated by DH(—) and 
PH2(—). The corresponding residues of wild type Ras-GRF are also 
shown. The C-terminus of the protein contains the catalytic domain 
(CDC25) which induces nucleotide exchange on Ras. In the N-ter-
minus of the molecule is an IQ domain which binds calmodulin and 
a putative coiled-coil region (CC). 
or the isolated DH domain of Ras-GRF purified from either 
insect or mammalian cells was unable to promote nucleotide 
exchange on RhoA, B, C, G, Racl, CDC42 or TC21, in vitro 
(data not shown). We cannot rule out the possibility that the 
DH domain of Ras-GRF activates other unidentified or less 
well-defined members of the Rho family of GTPases, or that 
we have failed to isolate the protem in a form that allows it to 
express this activity in vitro. 
Subsequently, we tested whether the DH domain of Ras-
GRF might perform a different function, by contributing to 
the regulation of the C-terminal Ras exchange (CDC25) do-
main of the protein. Therefore, we investigated the effect of 
mutating the DH domain on the ability of Ras-GRF to acti-
vate Ras. Hart et al. showed that several non-transforming 
mutants of Dbl also had impaired nucleotide exchange activ-
ity towards CDC42 [36]. One of these Dbl mutants contained 
conservative substitutions in a region of seven amino acids 
(640-646) which is highly conserved in Ras-GRF and other 
DH-containing proteins. Therefore, we made analogous mu-
tations in this region of Ras-GRF to examine the effect on 
enzyme activity (see DH(—) Ras-GRF in Fig. 1). 
Using a similar strategy, we also investigated the role of the 
adjacent PH (PH2) domain in Ras-GRF activation by mutat-
ing a highly conserved tryptophan (W573) to alanine and a 
nearby isoleucine to alanine (see (PH2(—)) Ras-GRF in Fig. 
1). Ras-GRF activity was measured indirectly by its ability to 
activate ERKl, which lies downstream of Ras in the pathway 
(Fig. 2). Epitope tagged ERKl was transiently expressed in 
293T cells with wild type or mutant Ras-GRF, or with vector 
alone. Following stimulation with the calcium ionophore, ion-
omycin, ERKl was immunoprecipitated from the cells and its 
activity was measured in an in vitro kinase assay. In cells 
lacking Ras-GRF, ionomycin produced a small ( ~ 3-fold) 
increase in ERKl activity. As shown previously [20], the ex-
pression of Ras-GRF magnified the calcium effect, demon-
strating Ras-GRF activation. In particular, Ras-GRF expres-
sion increased ERKl activity ~ 3-fold in the absence of 
stimulation and 27-fold in response to the addition of iono-
mycin. As previously shown, Ras-GRF functioned through 
Ras to activate ERK, since co-expression of dominant nega-
tive 17N Ras suppressed Ras-GRF activity in the presence 
and absence of calcium influx. 
Expression of either the DH(—) or PH2(—) Ras-GRF mu-
tants also increased ERKl activity, in the absence of stimu-
lation, although this effect was consistently smaller than that 
found for wild type Ras-GRF. Strikingly, activation of either 
DH(—) or PH2(—) Ras-GRF by calcium influx was severely 
suppressed. Immunoblotting of the cell extracts revealed that 
the protein levels of ERKl and Ras-GRF proteins did not 
vary significantly between each assay (data not shown). Thus, 
functional DH and PH domains are required for calcium in-
duced activation of Ras-GRF. 
3.2. Mutations in the DH and PH2 domains do not affect the 
activity of Ras-GRF in vitro 
Next, we investigated whether the inhibitory effects of the 
mutations in the DH and PH2 domains of Ras-GRF were due 
to a reduction in the intrinsic catalytic activity of the enzyme. 
To answer this question, we measured the activity of mutant 
Ras-GRF in vitro. Epitope tagged wild type and mutant Ras-
GRFs were purified from 293T cells transiently expressing the 
proteins. Their exchange activities were measured by their 
ability to induce GDP release from GST-Ras and subsequent 
binding of [oc-32P]GTP. Both D H ( - ) and PH2(-) mutants 
had exchange activities that were very similar to that of 
wild type Ras-GRF (Fig. 3). 
3.3. Mutations in the DH and PH2 domains do not affect the 
ability of Ras-GRF to bind calmodulin 
We have previously shown that the calcium-dependent 
binding of calmodulin to a conserved motif in the N-terminus 
of Ras-GRF is an essential event for Ras-GRF activation 
[20]. Therefore we examined whether or not the mutations 
in the DH and PH2 domains impaired the interaction between 
calmodulin and Ras-GRF. Epitope tagged wild type and mu-
tant Ras-GRF were transiently expressed in 293T cells, im-
munoprecipitated and identified by immunoblotting following 
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Fig. 2. Mutations in the DH and PH2 domains of Ras-GRF inhibit 
its activation by ionomycin-ERKl activation assay. 60 mm2 dishes 
of 293T cells were transiently transfected with 2 jig of pJ3M myc-
ERK1 and 0.5 ug of either wild type or mutant Ras-GRF, or vec-
tor alone as indicated. In some experiments, 2 u.g of 17N Ras was 
also co-expressed. Following serum starvation, cells were stimulated 
for 5 min with 5 uM ionomycin (black bars) or vehicle alone (grey 
bars). ERKl activity was measured by immune complex kinase as-
says using myelin basic protein as substrate. Phosphorylated sub-
strate was quantitated by a phosphorimager following SDS-PAGE. 
ERKl extracted from resting cells was given an arbitrary protein 
kinase activity value of 1. Results represent the average of three ex-
periments ± S.E.M. 





Fig. 3. Mutations in the DH and PH2 domains of Ras-GRF do not 
affect its activity in vitro. 250 ng of GDP-bound GST-Ras was in-
cubated at 30°C for the indicated times alone (□) or with approxi-
mately 150 ng of wild type (0) or mutant epitope-tagged Ras-GRF 
(O DH- ; A PH2-) in the presence of 2 uCi of [a-32P]GTP. 
NGlu-tagged Ras-GRF had been purified from 293T cells transi-
ently expressing the protein and GST-Ras had been purified from 
bacteria. An aliquot of each reaction mixture was spotted onto a ni-
trocellulose membrane, washed and the amount of [a-32P]GTP 
bound to each GTPase was determined by Cerenkov counting. 
100% represents maximal binding of [a-32P]GTP to each GTPase as 
measured by incubating the proteins at 30°C for 10 min with 4.5 
mM EDTA to induce nucleotide exchange. Data are representative 
of two experiments each performed in duplicate. 
dulin was detected after immunoblotting with an antibody 
against the protein (Fig. 4A, lower panel). As expected, wild 
type Ras-GRF bound calmodulin, while the IQ— mutant did 
not. Calmodulin co-precipitated with both the Ras-GRF 
D H ( - ) and the PH2(-) mutants. 
bers of the Rho GTPase family. Thus, if the Ras-GRF DH 
domain functions as an exchange factor, we have not been 
able to isolate the protein in an active form, or its substrate 
is an untested Rho family member. 
Instead, we have shown that the DH domain participates in 
Ras activation by Ras-GRF. Ras-GRF activity in vivo was 
measured by its ability to activate both its target Ras and 
ERK1, a kinase that lies downstream from Ras. In both as-
says, the DH mutation severely suppressed Ras-GRF's acti-
vation by calcium influx. In the ERK1 assay we also detected 
a small but reproducible decrease in the ability of the mutant 
Ras-GRF to activate Ras in the absence of calcium stimula-
tion. Since we could not detect a defect in the intrinsic nucleo-
tide exchange activity of this mutant as assayed in vitro, these 
findings suggest that the catalytic domain of the mutant may 
be incorrectly targeted to Ras in cells. This defect must be 
subtle because we could not detect a significant change in 
the distribution of the mutant between the cytosolic and par-
ticulate fractions of cells. Since the mutant also bound calm-
odulin as well as the wild type protein did, the DH domain 
may contribute a novel function, which is essential for proper 
Ras-GRF activity. 
All known DH domains are followed by PH domains, sug-
gesting that they function coordinately in cells. In Dbl, a 
mutation in the PH domain did not alter the protein's intrin-
sic nucleotide exchange activity, but it did block the protein's 
ability to oncogenically transform cells [38]. Similarly, muta-
tions in the PH2 domain of Ras-GRF blocked the protein's 
ability to respond to calcium influx in vivo. The mutations did 
3.4. Mutations in the DH and PH2 domains do not affect the 
cellular localization of Ras-GRF 
Ras-GRF is localized preferentially to the particulate frac-
tion even in unstimulated cells. We have recently shown that 
this localization is necessary but not sufficient for calcium to 
enhance Ras-GRF's ability to activate Ras in vivo [37]. Thus, 
we investigated whether altered cellular distribution might ac-
count for the loss in responsiveness of the DH and PH2 mu-
tants. Immunoblot analysis of cytosolic and crude particulate 
fractions from 293T cells transiently expressing either wild 
type or mutant Ras-GRFs failed to demonstrate a significant 
difference among them (Fig. 4B). A recent report [38] showed 
that the PH domain of Dbl, which is essential for transforma-
tion by this protein, may enable it to bind to cytoskeletal 
components found in the Triton X-100 insoluble fraction of 
cells. While some wild type Ras-GRF exists in the Triton X-
100 insoluble fraction, mutations in the DH and PH2 domains 
did not alter its association with this fraction (data not 
shown). 
4. Discussion 
Dbl and many other DH domain-containing proteins act as 
nucleotide exchange factors for Rho family GTPases. Since 
Ras-GRF possesses a DH domain in addition to its Ras ex-
change domain, it was proposed that Ras-GRF might func-
tion as a dual specificity exchange factor [22,23]. However, we 
could not detect such activity against well-characterized mem-
Fig. 4. The DH(-) and PH2(-) mutations do not inhibit calmodu-
lin binding to Ras-GRF and do not affect its subcellular distribu-
tion. A: Calmodulin binding: 100 mm2 dishes of 293T cells were 
transiently transfected with 10 ug of wild type or mutant epitope-
tagged NGlu Ras-GRF as indicated. Following cell lysis, Ras-GRF 
was immunoprecipitated from the cells using an antibody against 
the epitope which had been pre-bound to protein A Sepharose. The 
upper panel shows an immunoblot of immunoprecipitated Ras-GRF 
and the lower panel shows an immunoblot of co-precipitating calm-
odulin. B: Subcellular distribution: 60 mm2 dishes of 293T cells 
were transiently transfected with 3 |xg of wild type or mutant pMT3 
Ras-GRF as indicated. Cells were lysed in an isotonic buffer fol-
lowed by sonication. Unbroken cells and debris were removed by a 
10 000 X g spin, and the extracts were fractionated by ultracentrifu-
gation at 100 000 X g to yield supernatant (S) and particulate (P) 
fractions. 10 ug of each extract was purified by SDS-PAGE and 
Ras-GRF was identified following immunoblotting. 
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not dramatically affect the protein's intrinsic nucleotide ex-
change activity against Ras in vitro, its cellular localization, 
or its ability to bind to calmodulin in vivo. Thus, this domain 
may function with the DH domain to provide a distinct func-
tion required for proper activation of Ras by Ras-GRF. 
Interestingly, we have been unable to detect any difference 
between the in vitro exchange activities of Ras-GRF purified 
from either resting or ionomycin-stimulated cells. Further-
more, the presence of calmodulin does not alter the exchange 
activity of the enzyme in vitro [22]. Thus, additional cellular 
components may be required for full Ras-GRF activity. Such 
components could bind to the DH and PH2 domains. Such a 
component may fail to co-purify with the Ras-GRF, render-
ing it unresponsive to calmodulin binding vitro. Alternatively, 
mutations in either of these domains could indirectly inhibit 
the function of other domains that are known to be critical 
for Ras-GRF activation, such as the first PH domain or the 
coiled coil at the N-terminus of the protein [37]. Such a pos-
sibility could be tested in the future, if specific functions for 
the regions are elucidated. 
Previous experiments on SOS demonstrated that its DH 
and PH domains contribute to its ability to activate Ras. In 
particular, deletion of both of these domains in Drosophila 
SOS prevented it from functioning properly in a differentia-
tion pathway required for eye development [39]. Moreover, 
deletion of both the DH and PH domains of mammalian 
SOS inhibited the protein from activating Ras in transiently 
transfected COS cells [40]. However, deletion of either the PH 
or DH domain of SOS individually had no effect on the basal 
activity of SOS [40]. Here, we show that point mutations in 
either of these domains have a small inhibitory effect on the 
basal activity of Ras-GRF in vivo, and a large inhibitory 
effect on the protein's response to calcium influx. Analogous 
experiments on tyrosine kinase activation of SOS in the pre-
vious study were not performed, so it remains to be deter-
mined whether the DH and PH domains play similar roles in 
these two Ras exchange factors. 
Exchange factors for Ras have turned out to be complex 
macromolecules with multiple functional domains. This may 
potentially allow them to respond to and influence diverse 
cellular signals. The results presented here add support to 
the idea that DH domains may themselves be multifunctional. 
In addition to acting as activators of Rho-family GTPases, 
they may also contribute to Ras activation by participating in 
the coupling of extracellular signals to activation of Ras ex-
change factor domains. 
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